Literature DB >> 8669347

Diabetes and cognitive impairment: a community-based study of elderly subjects.

S C Croxson1, C Jagger.   

Abstract

To ascertain whether diabetes in elderly people is associated with cognitive impairment, we offered all residents of Melton Mowbray aged 75, 80 and 85 years both a modified glucose tolerance test (1985 WHO criteria) and Folstein mental state examination (MMSE, 23/24 cut-off). Analysis of the results, stratified by age, revealed that subjects with known diabetes were more likely than normal subjects to have low MMSE [odds ratio 3.30 (95% CI 1.3 to 8.5)], whilst newly found diabetic subjects were less likely to have low MMSE [odds ratio 5(-14) (95% CI 9(-25) to 0.003)]. The difference between known and newly found diabetic subjects might relate to duration of diabetes. The increased frequency of cognitive impairment in known diabetic subjects may be pertinent to the safe use of hypoglycaemic agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8669347     DOI: 10.1093/ageing/24.5.421

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  12 in total

1.  A genome-wide scan for common variants affecting the rate of age-related cognitive decline.

Authors:  Philip L De Jager; Joshua M Shulman; Lori B Chibnik; Brendan T Keenan; Towfique Raj; Robert S Wilson; Lei Yu; Sue E Leurgans; Dong Tran; Cristin Aubin; Christopher D Anderson; Alessandro Biffi; Jason J Corneveaux; Matthew J Huentelman; Jonathan Rosand; Mark J Daly; Amanda J Myers; Eric M Reiman; David A Bennett; Denis A Evans
Journal:  Neurobiol Aging       Date:  2011-11-04       Impact factor: 4.673

2.  Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.

Authors:  Qing-Guo Ren; Jing-Hao Chang; Wan-Jun Lu; Wei-Gang Gong; Hong Zhou
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

3.  Correlates of cognitive impairment in older Vietnamese.

Authors:  Amanda Leggett; Steven H Zarit; Chuong N Hoang; Ha T Nguyen
Journal:  Aging Ment Health       Date:  2013-05-22       Impact factor: 3.658

4.  An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease.

Authors:  Taner Shakir; Ahmed Y Coulibaly; Patrick G Kehoe
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

5.  Self management and patient understanding of diabetes in the older person.

Authors:  J Hewitt; L Smeeth; N Chaturvedi; C J Bulpitt; A E Fletcher
Journal:  Diabet Med       Date:  2011-01       Impact factor: 4.359

Review 6.  Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis.

Authors:  Carlos Peñaherrera-Oviedo; Daniel Moreno-Zambrano; Michael Palacios; María Carolina Duarte-Martinez; Carlos Cevallos; Ximena Gamboa; María Beatriz Jurado; Leonardo Tamariz; Ana Palacio; Rocío Santibañez
Journal:  Int J Chronic Dis       Date:  2015-08-04

Review 7.  Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.

Authors:  S W Seto; G Y Yang; H Kiat; A Bensoussan; Y W Kwan; D Chang
Journal:  Int J Endocrinol       Date:  2015-04-28       Impact factor: 3.257

8.  Genetic architecture of age-related cognitive decline in African Americans.

Authors:  Towfique Raj; Lori B Chibnik; Cristin McCabe; Andus Wong; Joseph M Replogle; Lei Yu; Sujuan Gao; Frederick W Unverzagt; Barbara Stranger; Jill Murrell; Lisa Barnes; Hugh C Hendrie; Tatiana Foroud; Anna Krichevsky; David A Bennett; Kathleen S Hall; Denis A Evans; Philip L De Jager
Journal:  Neurol Genet       Date:  2016-12-21

9.  Risk factors associated with post-stroke dementia: a systematic review and meta-analysis.

Authors:  Jesada Surawan; Suchat Areemit; Somsak Tiamkao; Theparak Sirithanawuthichai; Suprawita Saensak
Journal:  Neurol Int       Date:  2017-09-29

10.  A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset.

Authors:  Francis Hane; Carolyn Augusta; Owen Bai
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.